Pulmonary necrosis resulting from DNA vaccination against tuberculosis

被引:98
作者
Taylor, JL
Turner, OC
Basaraba, RJ
Belisle, JT
Huygen, K
Orme, IM [1 ]
机构
[1] Colorado State Univ, Dept Microbiol Immunol & Pathol, Mycobacteria Res Labs, Ft Collins, CO 80523 USA
[2] Inst Pasteur, Brussels, Belgium
关键词
D O I
10.1128/IAI.71.4.2192-2198.2003
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The use of DNA constructs encoding mycobacterial proteins is a promising new approach to vaccination against tuberculosis. A DNA vaccine encoding the hsp60 molecule of Mycobacterium leprae has previously been;shown to protect against intravenous infection of mice with Mycobacterium tuberculosis in both the prophylactic and immunotherapeutic modes. It is shown here, however, that this vaccine was not effective in a more realistic aerosol infection model or in a model of latent tuberculosis in the lungs. Moreover, when given in an immunotherapeutic model the immunized mice developed classical Koch reactions characterized by multifocal discrete regions of cellular necrosis throughout the lung granulomas. Similar and equally severe reactions were seen in mice given a vaccine with DNA coding for the Ag85 antigen of M. tuberculosis. This previously unanticipated safety problem indicates that DNA vaccines should be used with caution in individuals who may have already been exposed to tuberculosis.
引用
收藏
页码:2192 / 2198
页数:7
相关论文
共 28 条
[1]  
[Anonymous], 1891, Dtsch Med Wschr, DOI [10.1055/s-0029-1206198, DOI 10.1055/S-0029-1206198]
[2]   Evaluation of new vaccines in the mouse and guinea pig model of tuberculosis [J].
Baldwin, SL ;
D'Souza, C ;
Roberts, AD ;
Kelly, BP ;
Frank, AA ;
Lui, MA ;
Ulmer, JB ;
Huygen, K ;
McMurray, DM ;
Orme, IM .
INFECTION AND IMMUNITY, 1998, 66 (06) :2951-2959
[3]   Metronidazole therapy in mice infected with tuberculosis [J].
Brooks, JV ;
Furney, SK ;
Orme, IM .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1999, 43 (05) :1285-1288
[4]   EFFICACY OF BCG VACCINE IN THE PREVENTION OF TUBERCULOSIS - METAANALYSIS OF THE PUBLISHED LITERATURE [J].
COLDITZ, GA ;
BREWER, TF ;
BERKEY, CS ;
WILSON, ME ;
BURDICK, E ;
FINEBERG, HV ;
MOSTELLER, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1994, 271 (09) :698-702
[5]   Transient loss of resistance to pulmonary tuberculosis in p47phox-/- mice [J].
Cooper, AM ;
Segal, BH ;
Frank, AA ;
Holland, SM ;
Orme, IM .
INFECTION AND IMMUNITY, 2000, 68 (03) :1231-1234
[6]   Global burden of tuberculosis - Estimated incidence, prevalence, and mortality by country [J].
Dye, C ;
Scheele, S ;
Dolin, P ;
Pathania, V ;
Raviglione, RC .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (07) :677-686
[7]  
Flynn JL, 1998, J IMMUNOL, V160, P1796
[8]   Immunology of tuberculosis [J].
Flynn, JL ;
Chan, J .
ANNUAL REVIEW OF IMMUNOLOGY, 2001, 19 :93-129
[9]   SPLEEN-CELL CYTOKINE SECRETION IN MYCOBACTERIUM-BOVIS BCG-INFECTED MICE [J].
HUYGEN, K ;
ABRAMOWICZ, D ;
VANDENBUSSCHE, P ;
JACOBS, F ;
DEBRUYN, J ;
KENTOS, A ;
DROWART, A ;
VANVOOREN, JP ;
GOLDMAN, M .
INFECTION AND IMMUNITY, 1992, 60 (07) :2880-2886
[10]   Immunogenicity and protective efficacy of a tuberculosis DNA vaccine [J].
Huygen, K ;
Content, J ;
Denis, O ;
Montgomery, DL ;
Yawman, AM ;
Deck, RR ;
DeWitt, CM ;
Orme, IM ;
Baldwin, S ;
DSouza, C ;
Drowart, A ;
Lozes, E ;
Vandenbussche, P ;
VanVooren, JP ;
Liu, MA ;
Ulmer, JB .
NATURE MEDICINE, 1996, 2 (08) :893-898